Improving tools for studying the role of microbes in cancer.
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
This study is looking at how the tiny germs in our bodies might affect cancer and how we can use this information to improve cancer detection and treatment for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern Arizona University NIH-funded |
| Lab location | 1 site (Flagstaff, United States) |
| Project ID | NIH-10874466 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of how the microbiome, the collection of microorganisms in our bodies, influences cancer development and treatment. By developing advanced bioinformatics tools and platforms, the project aims to make it easier for researchers to analyze microbiome data related to various cancers, such as gastric, colon, and cervical cancer. Patients may benefit from improved cancer detection and treatment strategies that consider the role of microbial interactions in their health. The research will also include workshops to educate researchers on these new tools and methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with advanced cancers, particularly those related to the gastrointestinal tract or cervical region.
Not a fit: Patients with cancers not influenced by microbial factors or those who are not undergoing treatment may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer detection and treatment strategies by leveraging insights from the microbiome.
How similar studies have performed: Previous research has shown promising results in understanding the microbiome's role in cancer, indicating that this approach could yield significant insights.
Where this research is happening
Flagstaff, United States
- Northern Arizona University — Flagstaff, United States (Active)
Researchers
- Principal investigator: Caporaso, James Gregory — Northern Arizona University
- Study coordinator: Caporaso, James Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.